Dmitry is the founder and managing partner of 4BIO Capital Partners, a venture capital firm focused on advanced therapies. He trained as a neuroscientist. Before co-founding the firm, Dmitry spent many years doing academic research on optogenetics and gene therapy for CNS disease in Germany and the United Kingdom. Dmitry served on boards of several biotech companies including RetroSense Therapeutics, a gene therapy upstart recently sold to Allergan.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.